Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?
- PMID: 32424028
- DOI: 10.1136/annrheumdis-2020-217828
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?
Keywords: antirheumatic agents; cardiovascular diseases; hydroxychloroquine.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al.Ann Rheum Dis. 2021 Mar;80(3):e30. doi: 10.1136/annrheumdis-2020-217923. Epub 2020 May 18. Ann Rheum Dis. 2021. PMID: 32424027 No abstract available.
Comment on
-
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.Ann Rheum Dis. 2020 Jun;79(6):734-736. doi: 10.1136/annrheumdis-2020-217480. Epub 2020 Apr 15. Ann Rheum Dis. 2020. PMID: 32295786 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
